HEALTH OF WOMAN. 2016.5(111):130–136; doi 10.15574/HW.2016.111.130 
 

Modern aspects of women in menopause

Sukchanova А., Gervazuyk O.

Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine

Kiev city center of reproductive and perinatal medicine

The objective: investigated the effect of dietary supplements Valesan on neuro-vegetative symptoms in menopausal women.

Patients and methods. During the work it examined 68 women in menopause. Formed a core group of 48 women who took a dietary supplement Valesan and a control group of 20 women who were not taking any medications. The patients of both groups carried out the modification of lifestyle.

Results. Patients of the main group had significantly important signs of positive dynamics of the intake of dietary supplements Valesan. Thus, according to the results of the survey with the help of Zung scale after 3 months of absence Valesan depressive state was observed in 75% of women in the control group of patients in 25% (p<0.05). The calculation of the modified menopausal index also showed the effectiveness of a dietary supplement Valesan reception. The symptoms of menopausal disorders in women of the main group obviously decreased 3 months after receiving Valesan (p <0.05).

Conclusions. Pathological during menopause negatively affects the quality of life of women. The use of natural products to relieve symptoms of pathological menopause is a safe and affordable method to eliminate these symptoms. As a result of receiving the dietary supplement Valesan have significant majority of women noted improvement in the modified menopausal index, normalization of psychosomatic disorders, improve overall health, recovery cycle «sleep-wake», in connection with which operability improved and stabilized the emotional background.

Key words: climacteric disorders, dietary supplements, Valesan.

REFERENCES

1. Vihlyaeva EM. 2008. Postmenopauzalnaya terapiya. Vliyanie na svyazannyie s menopauzoy simptomyi, techenie hronicheskih zabolevaniy i kachestvo zhizni. M, «MEDpress-inform»:448.

2. De NV, Hripunova GI. 2008. Sovremennyie podhodyi k diagnostike, prognozirovaniyu techeniya i lecheniyu klimaktericheskogo sindroma u zhenschin. Saratovskiy nauchno-meditsinskiy zhurnal 3(21):125–130.

3. Komarov FI, Rapoport SI, Malinovskaya NK. 2005. Sutochnyie ritmyi v klinike vnutrennih bolezney. Klinich. meditsina 83;8:8–12.

4. Kryizhanovskaya IO. 2000. Sistemnyie mehanizmyi stareniya u zhenschin v peri- i postmenopauze, patogeneticheskoe obosnovanie strategii menopauzalnoy terapii. Avtoref. dis. d-ra med. nauk. Rostov-na-Donu.

5. Saveleva GM, Breusenko VG. 1998. Postmenopauza. Fiziologiya i patologiya. Vestnik Rossiyskoy assotsiatsii akusherstva i ginekologii 2:45–49.

6. Smetnik VP. 1997. Klinika i diagnostika klimaktericheskih rasstroystv. Klimakteriy i postmenopauza 1:5–8.

7. Tatevosyan AG. 2000. Korrektsiya psihovegetativnyih rasstroystv u bolnyih s klimaktericheskim sindromom. Avtoref. diss. kand. med. nauk. M:25.

8. Tolstyih MP, Budnevskiy SV, Gadzhiev AI. 2006. Teoriticheskoe obosnovanie primeneniya serotonina v klinicheskoy praktike. Almanah klinicheskoy meditsinyi 11:133–138.

9. Shamsheva DS. 2014. Sindrom obstruktivnogo apnoe sna: sovremennoe sostoyanie problemyi. Lechebnoe delo 1:4–15.

10. Shaposhnik OD. 2005. Klimaks i serdechno-sosudistyie zabolevaniya. Uchebnoe posobie dlya vrachey. Chelyabinsk:75. PMid:16019715

11. Dancey DR, Hanly PJ, Soong C, Lee B, Hoffstein V. 2001. Impact of menopause on the prevalence and severity of sleep apnea. Chest. 120:151–155. PubMed: 11451831. http://dx.doi.org/10.1378/chest.120.1.151; PMid:11451831

12. Haimov I, Lavie P, Laudon M, Herer P, Vigder C et al. 1995. Melatonin replacement therapy of elderly insomniacs. Sleep. 18:598–603. PMid:8552931

13. Anderson D, Yoshizawa T, Gollschewski S et al. 2004. Menopause in Australia and Japan: effects of country of residence in menopausal status and menopausal symptoms. Climacteric. 2:165–174. http://dx.doi.org/10.1080/13697130410001713760

14. Quan SF, Howard BV, Iber C et al. 1997. The Sleep Heart Health Study: design, rationale, and methods. Sleep. 20:1077–1085. PMid:9493915

15. Resta O, Bonfitto P, Sabato R, De Pergola G, Barbaro MP. 2004. Prevalence of obstructive sleep apnoea in a sample of obese women: effect of menopause. Diabetes Nutr Metab. 17:296–303. PMid:16295052

16. Soares J, Masana M, Ershahin C, Dubocovich M. 2003. Functional melatonin receptors in rat ovaries at various stages of the estrous cycle. J. Pharmacol.Exp. Ther. 306:694–702. http://dx.doi.org/10.1124/jpet.103.049916; PMid:12721330

17. Tamanna S, Geraci SA. 2013, August. Major sleep disorders among women: (women’s health series) Southern Medical Journal &. 106;8:470–478. http://dx.doi.org/10.1097/SMJ.0b013e3182a15af5; PMid:23912143

18. Toffol E, Kalleinen N, Haukka J, Vakkuri O, Partonen T et al. 2014. Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life. Menopause 21:493–500. http://dx.doi.org/10.1097/GME.0b013e3182a6c8f3; PMid:24065140

19. Vakkuri O, Kivelд A, Leppдluoto J, Valtonen M, Kauppila A. 1996. Decrease in melatonin precedes follicle-stimulating hormone increase during perimenopause. Eur J Endocrinol. 135:188–192. http://dx.doi.org/10.1530/eje.0.1350188; PMid:8810731